Literature DB >> 12672177

OMERACT 6 brings new perspectives to rheumatology measurement research.

Kenneth G Saag.   

Abstract

Mesh：

Year:  2003        PMID： 12672177

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  14 in total

1.  Patient centred outcomes in osteoarthritis.

Authors:  J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

Review 2.  OMERACT 7 psoriatic arthritis workshop: synopsis.

Authors:  D D Gladman; V Strand; P J Mease; C Antoni; P Nash; A Kavanaugh
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 3.  Treat to Target in Axial Spondyloarthritis: Pros, Cons, and Future Directions.

Authors:  Jean W Liew; Maureen Dubreuil
Journal:  Rheum Dis Clin North Am       Date:  2020-05       Impact factor: 2.670

Review 4.  Patients' and clinicians' research priorities.

Authors:  Ruth J Stewart; Jenny Caird; Kathryn Oliver; Sandy Oliver
Journal:  Health Expect       Date:  2010-12-22       Impact factor: 3.377

5.  Performance of health status measures with a pen based personal digital assistant.

Authors:  T K Kvien; P Mowinckel; T Heiberg; K L Dammann; Ø Dale; G J Aanerud; T N Alme; T Uhlig
Journal:  Ann Rheum Dis       Date:  2005-04-20       Impact factor: 19.103

6.  Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis.

Authors:  T Heiberg; A Finset; T Uhlig; T K Kvien
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

7.  Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state.

Authors:  F Tubach; P Ravaud; G Baron; B Falissard; I Logeart; N Bellamy; C Bombardier; D Felson; M Hochberg; D van der Heijde; M Dougados
Journal:  Ann Rheum Dis       Date:  2004-05-06       Impact factor: 19.103

Review 8.  Quality-of-life assessment in rheumatoid arthritis.

Authors:  Anthony S Russell
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

9.  Evaluation of the patient acceptable symptom state in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis.

Authors:  Maxime Dougados; Alan Moore; Shaohua Yu; Xavier Gitton
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences.

Authors:  Maarten de Wit; Tineke Abma; Marije Koelewijn-van Loon; Sarah Collins; John Kirwan
Journal:  BMJ Open       Date:  2013-05-09       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.